NCT05800106 2023-04-10A Bioequivalence Study of Sunitinib Malate Capsules.Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 1 Completed24 enrolled
NCT00428220 2019-06-27A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.PfizerPhase NA Completed223 enrolled 8 charts